Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Defibrillators, Implantable | 14 | 2016 | 190 | 1.740 |
Why?
|
| Cardiac Pacing, Artificial | 8 | 2012 | 116 | 1.290 |
Why?
|
| Sarcoidosis | 6 | 2016 | 93 | 1.120 |
Why?
|
| Pacemaker, Artificial | 7 | 2013 | 119 | 1.020 |
Why?
|
| Electrodes, Implanted | 4 | 2013 | 191 | 0.870 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2014 | 236 | 0.830 |
Why?
|
| Heart Failure | 11 | 2018 | 1491 | 0.770 |
Why?
|
| Cardiomyopathies | 4 | 2016 | 315 | 0.750 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2015 | 264 | 0.580 |
Why?
|
| Long QT Syndrome | 2 | 2016 | 38 | 0.560 |
Why?
|
| Cardiac Resynchronization Therapy | 6 | 2018 | 96 | 0.530 |
Why?
|
| Equipment Failure Analysis | 5 | 2013 | 88 | 0.520 |
Why?
|
| Ventricular Fibrillation | 2 | 2013 | 73 | 0.460 |
Why?
|
| Gadolinium | 1 | 2014 | 95 | 0.400 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 122 | 0.390 |
Why?
|
| Coronary Angiography | 1 | 2013 | 237 | 0.360 |
Why?
|
| Echocardiography | 5 | 2016 | 783 | 0.360 |
Why?
|
| Electrocardiography | 8 | 2016 | 527 | 0.330 |
Why?
|
| Atrial Fibrillation | 7 | 2015 | 460 | 0.310 |
Why?
|
| Ultrasonography, Doppler | 1 | 2009 | 76 | 0.290 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 360 | 0.290 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 387 | 0.280 |
Why?
|
| Safety | 1 | 2009 | 138 | 0.280 |
Why?
|
| Cardiac Electrophysiology | 1 | 2008 | 11 | 0.280 |
Why?
|
| Ventricular Function, Left | 4 | 2016 | 540 | 0.270 |
Why?
|
| Tachycardia, Ventricular | 3 | 2016 | 180 | 0.260 |
Why?
|
| Catheter Ablation | 4 | 2016 | 381 | 0.260 |
Why?
|
| Electric Countershock | 3 | 2016 | 77 | 0.260 |
Why?
|
| Bundle-Branch Block | 1 | 2007 | 68 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3606 | 0.220 |
Why?
|
| Quality of Life | 4 | 2016 | 1891 | 0.220 |
Why?
|
| Heart Ventricles | 1 | 2009 | 664 | 0.220 |
Why?
|
| Humans | 39 | 2018 | 97893 | 0.210 |
Why?
|
| Middle Aged | 18 | 2016 | 29352 | 0.200 |
Why?
|
| Male | 26 | 2018 | 46995 | 0.190 |
Why?
|
| Female | 23 | 2018 | 51463 | 0.190 |
Why?
|
| Heart Diseases | 2 | 2016 | 268 | 0.180 |
Why?
|
| Prevalence | 4 | 2016 | 1384 | 0.180 |
Why?
|
| Stroke Volume | 6 | 2016 | 464 | 0.160 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 2 | 2016 | 20 | 0.150 |
Why?
|
| Risk Assessment | 3 | 2016 | 2580 | 0.150 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2018 | 22 | 0.140 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 48 | 0.140 |
Why?
|
| Equipment Design | 5 | 2016 | 425 | 0.140 |
Why?
|
| Prognosis | 6 | 2018 | 4112 | 0.140 |
Why?
|
| Equipment Failure | 4 | 2012 | 119 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 208 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2010 | 45 | 0.120 |
Why?
|
| Heart Failure, Systolic | 1 | 2016 | 5 | 0.120 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2014 | 85 | 0.120 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2016 | 53 | 0.120 |
Why?
|
| Treatment Outcome | 11 | 2016 | 9682 | 0.120 |
Why?
|
| Heart Rate | 2 | 2016 | 534 | 0.110 |
Why?
|
| Adult | 10 | 2016 | 29453 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2016 | 257 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2016 | 642 | 0.100 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2014 | 26 | 0.100 |
Why?
|
| Differential Threshold | 1 | 2013 | 11 | 0.100 |
Why?
|
| Hospitalization | 2 | 2016 | 982 | 0.100 |
Why?
|
| Image Enhancement | 1 | 2016 | 503 | 0.100 |
Why?
|
| Causality | 1 | 2013 | 83 | 0.100 |
Why?
|
| Sex Factors | 1 | 2016 | 1137 | 0.100 |
Why?
|
| Anesthesiology | 1 | 2015 | 171 | 0.090 |
Why?
|
| Cardiology | 1 | 2014 | 124 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 228 | 0.090 |
Why?
|
| Consensus | 1 | 2014 | 315 | 0.090 |
Why?
|
| Aged | 10 | 2018 | 21701 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2016 | 10947 | 0.090 |
Why?
|
| Oxygen Consumption | 2 | 2015 | 239 | 0.090 |
Why?
|
| Systole | 1 | 2011 | 81 | 0.090 |
Why?
|
| Prosthesis Design | 2 | 2013 | 308 | 0.080 |
Why?
|
| Acetanilides | 1 | 2010 | 5 | 0.080 |
Why?
|
| Syndactyly | 1 | 2010 | 14 | 0.080 |
Why?
|
| Brugada Syndrome | 1 | 2010 | 6 | 0.080 |
Why?
|
| Ventricular Septum | 1 | 2010 | 15 | 0.080 |
Why?
|
| Ventricular Remodeling | 2 | 2009 | 108 | 0.080 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 331 | 0.080 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2010 | 37 | 0.080 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 151 | 0.080 |
Why?
|
| Anticoagulants | 1 | 2014 | 483 | 0.080 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2010 | 77 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 508 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2014 | 682 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2010 | 91 | 0.080 |
Why?
|
| Punctures | 1 | 2009 | 29 | 0.080 |
Why?
|
| Needles | 1 | 2009 | 43 | 0.080 |
Why?
|
| Comorbidity | 1 | 2013 | 1032 | 0.080 |
Why?
|
| Heart Septum | 1 | 2009 | 45 | 0.080 |
Why?
|
| Silicone Elastomers | 1 | 2008 | 6 | 0.070 |
Why?
|
| Polyurethanes | 1 | 2008 | 14 | 0.070 |
Why?
|
| Incidence | 1 | 2013 | 1776 | 0.070 |
Why?
|
| Electrocoagulation | 1 | 2008 | 23 | 0.070 |
Why?
|
| Chicago | 1 | 2013 | 1513 | 0.070 |
Why?
|
| Piperazines | 1 | 2010 | 306 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1567 | 0.070 |
Why?
|
| Myocardium | 1 | 2011 | 578 | 0.070 |
Why?
|
| Hot Temperature | 1 | 2008 | 228 | 0.070 |
Why?
|
| Medicare | 1 | 2011 | 467 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 91 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2007 | 299 | 0.060 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 137 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2007 | 384 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 394 | 0.060 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2009 | 339 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2007 | 143 | 0.060 |
Why?
|
| Risk Factors | 3 | 2013 | 6224 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2006 | 92 | 0.060 |
Why?
|
| Body Height | 1 | 2006 | 109 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2006 | 101 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2013 | 916 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 902 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2006 | 100 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 7386 | 0.060 |
Why?
|
| Stroke | 1 | 2014 | 1154 | 0.050 |
Why?
|
| Research Design | 1 | 2007 | 650 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2006 | 251 | 0.050 |
Why?
|
| Heart Block | 1 | 2003 | 34 | 0.050 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2012 | 23 | 0.050 |
Why?
|
| Exercise Test | 2 | 2015 | 158 | 0.040 |
Why?
|
| Decision Support Techniques | 2 | 2016 | 194 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 523 | 0.040 |
Why?
|
| Atrial Flutter | 1 | 2001 | 45 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 983 | 0.040 |
Why?
|
| Monitoring, Physiologic | 2 | 2012 | 263 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 5555 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2001 | 227 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1778 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2001 | 231 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 321 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2783 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2016 | 36 | 0.030 |
Why?
|
| Device Approval | 1 | 2016 | 15 | 0.030 |
Why?
|
| Models, Economic | 1 | 2016 | 62 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2016 | 76 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 166 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 117 | 0.030 |
Why?
|
| Laboratories | 1 | 2015 | 47 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2015 | 144 | 0.030 |
Why?
|
| Sick Sinus Syndrome | 1 | 2012 | 8 | 0.020 |
Why?
|
| Contraindications | 1 | 2012 | 66 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 309 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 1254 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2012 | 3202 | 0.020 |
Why?
|
| Patient Selection | 1 | 2016 | 720 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2012 | 43 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1944 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 1224 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 2016 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1750 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 1609 | 0.020 |
Why?
|
| Ranolazine | 1 | 2010 | 3 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 1011 | 0.020 |
Why?
|
| Verapamil | 1 | 2010 | 32 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 155 | 0.020 |
Why?
|
| Ventricular Dysfunction | 1 | 2010 | 24 | 0.020 |
Why?
|
| Registries | 2 | 2006 | 1120 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2014 | 520 | 0.020 |
Why?
|
| Device Removal | 1 | 2011 | 170 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2010 | 155 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2009 | 142 | 0.020 |
Why?
|
| Materials Testing | 1 | 2008 | 95 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 129 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 762 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 4023 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2009 | 193 | 0.020 |
Why?
|
| Observer Variation | 1 | 2009 | 579 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2009 | 370 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4798 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 985 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 968 | 0.020 |
Why?
|
| Body Surface Area | 1 | 2006 | 38 | 0.010 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 46 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 98 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2006 | 111 | 0.010 |
Why?
|
| United States | 2 | 2011 | 8183 | 0.010 |
Why?
|
| Creatinine | 1 | 2006 | 312 | 0.010 |
Why?
|
| Heart Atria | 1 | 2006 | 255 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 889 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1009 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 2008 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2006 | 489 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 403 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 1273 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 1995 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 356 | 0.010 |
Why?
|
| Ethanol | 1 | 2003 | 282 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 7504 | 0.010 |
Why?
|
| Adolescent | 1 | 2009 | 10078 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2001 | 2680 | 0.000 |
Why?
|